alex berenson new york times another may endless stream stories regarding olanzapine questionable best marketing practices i start quoting latest piece illinois vermont part coordinated five state civil investigation way lilly promoted zyprexa treatment schizophrenia bipolar disorder states investigating whether lilly tried hide zyprexa risk causing weight gain risks associated diabetes whether company promoted zyprexa use patients schizophrenia bipolar disorder federal laws prohibit called label marketing although doctors may prescribe drug disease believe drug help orders thursday yesterday first formal demands lilly documents state attorneys indicate escalation investigation according ms hagan julie brill assistant attorney general vermont background story please feel free see posts make sure also check ahrp site much information zyprexa case